Male circumcision and risk of male-to-female HIV-1 transmission: A multinational prospective study in African HIV-1-serodiscordant couples

AIDS

Volumn 24, Issue 5, 2010, Pages 737-744

  Baeten, Jared M ^a   Donnell, Deborah ^b   Kapiga, Saidi H ^d,e   Ronald, Allan ^f   John Stewart, Grace ^a   Inambao, Mubiana ^c   Manongi, Rachel ^e   Vwalika, Bellington ^c   Celum, Connie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Rwanda Zambia HIV Research Group   (Zambia)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^f UNIVERSITY OF MANITOBA   (Canada)

Author keywords

HIV 1 discordant couples; HIV 1 transmission; Male circumcision

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; PLACEBO;

ADULT; AFRICA; ARTICLE; BLOOD SAMPLING; CIRCUMCISION; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEROLOGY; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CIRCUMCISION, MALE; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HIV-2; HUMANS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 77949401903     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833616e0     Document Type: Article

References (23)

1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005; 2:e298.
2. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalu-goda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666.
3. Bailey RC, Moses S,Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: arandomisedcontrolledtrial.Lancet 2007; 369:643-656.
4. Bailey RC, Plummer FA, Moses S. Male circumcision and HIV prevention: current knowledge and future research directions. Lancet Infect Dis 2001; 1:223-231.
5. Biesalski HK. Comparative assessment of the toxicology of vitamin A and retinoids in man. Toxicology 1989; 57:117-161.
6. Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA. Male circumcision for HIV prevention: from evidence to action? AIDS 2008; 22:567-574
7. WHO/UNAIDS. New data on male circumcision and HIV prevention: policy and programme implications. Geneva: WHO; 2007.
8. Kapiga SH, Lyamuya EF, Kwihula GK, Hunter DJ. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS 1998; 12:75-84.
9. Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwadda D, Mangen FW, et al. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS 2000; 14:2371-2381.
10. Turner AN, Morrison CS, Padian NS, Kaufman JS, Salata RA, Chipato T, et al. Men's circumcision status and women's risk of HIVacquisitioninZimbabweandUganda.AIDS2007;21:1779-1789.
11. Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, Nalugoda F, et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet 2009; 374: 229-237.
12. Lingappa JR, Kahle E, Mugo N, Mujugira A, Magaret A, Baeten J, et al. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the Partners study. PLoS ONE 2009; 4:e5272.
13. Celum C, Wald A, Lingappa JR, Magaret A, Wang RS, Mugo N, et al. Twice-daily acyclovir to reduce HIV-1 transmission from HIV-1/HSV-2 co-infected persons within HIV-1 serodiscordant couples: a randomized, double-blind, placebo-controlled trial. 5th International AIDS Society Conference on HIV Pathogen-esis, Treatment and Prevention. Cape Town, South Africa, 19-22 July 2009. Abstract WELBC101.
14. Laeyendecker O, Henson C, Gray RH, Nguyen RH, Horne BJ, Wawer MJ, et al. Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans. J Clin Microbiol 2004; 42:1794-1796.
15. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of western blot (immunoblot) and glycoprotein G-specific im-munodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988; 26:662-667.
16. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
17. Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360:1298-1309.
18. Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, LagardeE, Auvert B. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis 2009; 199:958-964.
19. Sobngwi-Tambekou J, Taljaard D, Nieuwoudt M, Lissouba P, Puren A, Auvert B. Male circumcision and Neisseria gonor-rhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention. Sex Transm Infect 2009; 85:116-120.
20. Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, Watya S, et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2009; 200:42 e41-42 e47.
21. Weiss HA, Hankins CA, Dickson K. Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis 2009; 9:669-677.
22. Hallett TB, Singh K, Smith JA, White RG, Abu-Raddad LJ, Garnett GP. Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One 2008; 3:e2212.
23. Baeten JM, Celum C, Coates TJ. Male circumcision and HIV risks and benefits for women. Lancet 2009; 374:182-184.